Publication Month: Jul 2022 |
Report Code: TIPRE00029530
| No. of Pages:
| Category: Food and Beverages
| Status: Published
No. of Pages 130
Probiotics are live bacteria and/or yeast, which benefit the person's gut health. Various benefits of probiotic supplements include boosting the gut microbiome, restoring balance to the microbiome, and supporting the immune system. Such benefits have surged its use among the target audience, which includes infants, children, and maternal women. Parents are increasingly focusing on their child’s nutrition and well-being, driving the market. Also, the increasing adoption of probiotic supplements among pregnant women has boosted the market substantially. Constant R&D taking place in this category across the globe will uplift the market growth in the coming years
In 2020, North America held the largest share of the global infant, child, and maternal probiotic supplements market, and Asia Pacific is estimated to register the fastest CAGR during the forecast period. Rising population, economic development, and an increase in disposable income are some factors contributing to the market's growth. Population in emerging economies, such as India, China, and Japan, are adopting nutritional supplements to improve the growth and development of children. Moreover, the increased infant mortality rate in emerging economies has fueled the demand for probiotic supplements in the region. For instance, according to the World Bank, in 2020, the infant mortality rate in East Asia Pacific was 11 per 1,000 live births.
|Market Size Value in||US$ 604.94 Million in 2021|
|Market Size Value by||US$ 1,081.70 Million by 2028|
|Growth rate||CAGR of 8.7% from 2022 to 2028|
|No. of Pages||130|
|No. of Tables||44|
|No. of Charts & Figures||61|
|Historical data available||Yes|
|Segments covered||Form, and End User|
|Regional scope||North America; Europe; Asia Pacific; Latin America; MEA|
|Country scope||US, UK, Canada, Germany, France, Italy, Australia, Russia, China, Japan, South Korea, Saudi Arabia, Brazil, Argentina|
|Report coverage||Revenue forecast, company ranking, competitive landscape, growth factors, and trends|
|Free Sample Copy Available|
Before the onset of the COVID-19 pandemic, the infant, child, and maternal probiotic supplements market was mainly driven by the rising focus of parents on specific infant nutrition and the increasing demand for nutritional supplements tailored according to the needs of pregnant women. However, the market faced unprecedented challenges after the outbreak in 2020. Manufacturers of infant, child, and maternal probiotic supplements faced significant challenges due to supply chain constraints caused by nationwide lockdowns, trade bans, and travel restrictions. Supply chain disruptions created a shortage of raw materials, which affected the production and distribution of various products, leading to increased prices.
In 2021, various economies resumed operations as governments announced relaxation in the previously imposed restrictions, which boosted the global market. Moreover, production facilities were permitted to operate at full capacity, which helped them overcome the demand and supply gap and other repercussions. As numerous citizens of many countries were fully vaccinated by 2021, market players focused on increasing their production to revive their businesses.
Probiotics lower the risk of pre-eclampsia in pregnant women, a health condition resulting in high blood pressure and high protein levels in urine. Probiotic supplements also ensure better immunity for pregnant women, which helps fight chronic diseases and ensure the baby's good health. Lactobacillus acidophilus, Bifidobacterium bifidum, and Saccharomyces boulardii are among the most effective and widely used probiotic strains in prenatal probiotic supplements. These strains help to maintain a healthy intestinal flora and reduce the risk of various allergies, diseases, and complications, including gestational diabetes and pre-eclampsia. The growing awareness about the benefits of probiotic supplements among pregnant women is substantially driving the infant, child, and maternal probiotic supplements market.
Based on form, the infant, child, and maternal probiotic supplements market is categorized into capsules and softgels, gummies, liquid, and others . The others segment held the largest share in the market during the forecast period. However, the gummies segment is expected to register the highest CAGR during the forecast period. Sweet and easy-to-consume probiotic gummies are available in appealing colors and shapes (such as teddy bears) and various flavors. Several manufacturers are engaged in product innovations to meet the growing demands of adults and children. Such strategic developments by manufacturers to diversify their product range is likely to propel the demand for infant, child, and maternal probiotic supplement gummies in the coming years.
Based on End User, the infant, child, and maternal probiotic supplements market is segmented into infants and toddlers, children, and maternal women. The children segment accounted for the largest market share in 2020. Probiotic supplements are gaining popularity in these children as they play a vital role in relieving colic, acute constipation, and acid reflux. Some researchers have shown that probiotics can help prevent antibiotic-related diarrhea in children, so pediatricians often include probiotic supplements while prescribing antibiotics.
Major players operating in the infant, child, and maternal probiotic supplements market include Bayer Corporation; Nestle S.A.; Mommy’s Bliss Inc.; LoveBug Probiotics; BioGaia AB; MaryRuth Organics, LLC; Pharmavite LLC; Evolve Biosystems; Biomeology; and Nordic Naturals. These companies are emphasizing on new product launches and geographical expansions to meet the growing consumer demand worldwide. They have a widespread global presence, which provides them to serve a large set of customers from all over the world and subsequently increases their market share. These market players focus heavily on new product launches and regional expansions to increase their product range in specialty portfolios.